Safety Profile of Cough and Cold Medication Use in Pediatrics
Open Access
- 1 June 2017
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 139 (6) , e20163070
Abstract
BACKGROUND AND OBJECTIVES: The safety of cough and cold medication (CCM) use in children has been questioned. We describe the safety profile of CCMs in children <12 years of age from a multisystem surveillance program. METHODS: Cases with adverse events (AEs) after ingestion of at least 1 index CCM ingredient (brompheniramine, chlorpheniramine, dextromethorphan, diphenhydramine, doxylamine, guaifenesin, phenylephrine, and pseudoephedrine) in children 20% of all cases included tachycardia, somnolence, hallucinations, ataxia, mydriasis, and agitation. Twenty cases (0.6%) resulted in death; most were in children <2 years of age (70.0%) and none involved a therapeutic dose. The overall reported AE rate was 0.573 cases per 1 million units (ie, tablets, gelatin capsules, or liquid equivalent) sold (95% confidence interval, 0.553–0.593) or 1 case per 1.75 million units. CONCLUSIONS: The rate of AEs associated with CCMs in children was low. Fatalities occurred even less frequently. No fatality involved a therapeutic dose. Accidental unsupervised ingestions were the most common exposure types and single-ingredient, pediatric liquid formulations were the most commonly reported products. These characteristics present an opportunity for targeted prevention efforts.Keywords
This publication has 14 references indexed in Scilit:
- Over-the-counter (OTC) medications for acute cough in children and adults in community settingsCochrane Database of Systematic Reviews, 2014
- The Impact of Pediatric Labeling Changes on Prescribing Patterns of Cough and Cold MedicationsThe Journal of Pediatrics, 2014
- Cough and Cold Medication Adverse Events After Market Withdrawal and Labeling RevisionPediatrics, 2013
- Effect of Cough and Cold Medication Restriction and Label Changes on Pediatric Ingestions Reported to United States Poison CentersThe Journal of Pediatrics, 2013
- Cold Preparation Use in Young ChildrenClinical Pediatrics, 2013
- Effect of Cough and Cold Medication Withdrawal and Warning on Ingestions by Young Children Reported to Texas Poison CentersPediatric Emergency Care, 2012
- Physician and Parent Response to the FDA Advisory About Use of Over-the-Counter Cough and Cold MedicationsAcademic Pediatrics, 2010
- Pediatric Fatalities Associated With Over the Counter (Nonprescription) Cough and Cold MedicationsAnnals of Emergency Medicine, 2009
- Cough and Cold Medication Use by US Children, 1999–2006: Results From the Slone SurveyPediatrics, 2008
- Dose-response relationship with increasing doses of dextromethorphan for children with coughClinical Therapeutics, 2004